Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Decreased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,600 shares of the medical equipment provider’s stock after selling 16,189 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Intuitive Surgical were worth $19,626,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the fourth quarter worth about $28,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter worth about $38,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,240 shares of company stock valued at $3,529,040. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $573.74 on Wednesday. The stock has a market cap of $204.35 billion, a price-to-earnings ratio of 89.51, a PEG ratio of 5.85 and a beta of 1.39. The business has a 50 day simple moving average of $567.01 and a 200 day simple moving average of $527.27. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on ISRG shares. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.